InsidersTradesSigma
Explore the full record of transactions filed by Brady Todd C, Chairman & CEO. Officer active across 1 companies, notably Aldeyra Therapeutics, Inc.. In total, 1 reports have been published. The latest transaction was filed on 30 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Todd C. Brady is the President and CEO of Aldeyra Therapeutics, Inc. He leads the company with a strategic vision focused on innovation and growth. His leadership is essential for navigating a constantly evolving business environment and achieving Aldeyra's objectives.